Aemetis, Inc. (NASDAQ:AMTX) Sees Large Increase in Short Interest

Aemetis, Inc. (NASDAQ:AMTX) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 5,670,000 shares, a growth of 5.8% from the November 30th total of 5,360,000 shares. Based on an average daily trading volume, of 729,000 shares, the days-to-cover ratio is presently 7.8 days.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. FMR LLC increased its position in Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after purchasing an additional 9,137 shares during the period. Hutchinson Capital Management CA purchased a new stake in shares of Aemetis in the second quarter valued at approximately $70,000. Barclays PLC grew its holdings in Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares during the period. Rhumbline Advisers raised its position in Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares in the last quarter. Finally, Wellington Management Group LLP acquired a new stake in Aemetis in the third quarter valued at $177,000. 27.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AMTX has been the subject of several research analyst reports. HC Wainwright reissued a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a report on Monday, December 23rd. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research note on Wednesday, December 25th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Trading Down 4.3 %

Shares of AMTX stock opened at $2.69 on Thursday. Aemetis has a twelve month low of $2.10 and a twelve month high of $7.03. The business’s 50 day moving average is $3.27 and its two-hundred day moving average is $2.98. The company has a market capitalization of $133.79 million, a P/E ratio of -1.19 and a beta of 1.35.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to analysts’ expectations of $77.79 million. During the same quarter last year, the business earned ($0.59) earnings per share. As a group, equities analysts predict that Aemetis will post -2.02 earnings per share for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.